Hippocampal circuit dysfunction in psychosis
Abstract Despite strong evidence of the neurodevelopmental origins of psychosis, current pharmacological treatment is not usually initiated until after a clinical diagnosis is made, and is focussed on antagonising striatal dopamine receptors. These drugs are only partially effective, have serious si...
Main Authors: | Samuel Knight, Robert McCutcheon, Daniella Dwir, Anthony A. Grace, Owen O’Daly, Philip McGuire, Gemma Modinos |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-022-02115-5 |
Similar Items
-
Correction: Hippocampal circuit dysfunction in psychosis
by: Samuel Knight, et al.
Published: (2022-09-01) -
Effects of benzodiazepine exposure on real-world clinical outcomes in individuals at clinical high risk for psychosis
by: Livingston, NR, et al.
Published: (2024) -
Pattern classification of brain activation during emotional processing in subclinical depression: psychosis proneness as potential confounding factor
by: Gemma Modinos, et al.
Published: (2013-02-01) -
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
by: Livingston, NR, et al.
Published: (2024) -
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
by: McCutcheon, RA, et al.
Published: (2023)